External Guide Sequence Oligozyme (VimRx)

N/A

Report date: 2025/10/28 15:11:26
NME

Base Information

Drug NameExternal Guide Sequence Oligozyme (VimRx)
Drug Alias NameInnoPhorRILON oligozymes (VimRx)hepatitis B therapeutics (VimRx)external guide sequence oligozyme (Nexell)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Ribozyme
Mechanisms of ActionEnzymes modulatorsRNA modulators
TargetsEnzymesRibonucleic Acid
Therapy Area/IndicationsInflammationPsoriasisLeukemia, Promyelocytic, Acute +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNexell Therapeutics IncInnovir Laboratories Inc
Active IndicationsN/A
Inactive IndicationsInflammationPsoriasisLeukemia, Promyelocytic, Acute +[5] 

Other Information

ATC CodeN/A
Related LinksN/A